KORU Medical Systems, Inc. (KRMD)
Full history for every metric is available with a Kvantra account
No price history available.
Key financial summary
Financials in USD| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E | ||
|---|---|---|---|---|---|---|---|---|---|
| Total revenue | $m | 24 | 23 | 28 | 29 | 34 | 41 | 45 | 48 |
| Operating profit | $m | -3 | -2 | ||||||
| Net profit | $m | -1 | -5 | -9 | -14 | -6 | -3 | -2 | -2 |
| EPS reported | $ | -0.06 | -0.04 | ||||||
| Operating cashflow per share | $ | 0.01 | 0.03 | ||||||
| Capex per share | $ | 0.02 | 0.02 | ||||||
| FCF per share | $ | -0.01 | 0.01 | ||||||
| Free cash flow | $m | -0 | 0 | ||||||
| Net debt | $m | -5 | -8 | ||||||
| Book value equity | $m | 17 | 18 | ||||||
| Book value per share | $ | 0.37 | 0.36 | ||||||
| Number of shares | m | 46.19 | 49.51 | ||||||
| DPS (TTM paid) | $ | 0.00 | 0.00 |
Financial summary
Financials in USD| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E | ||
|---|---|---|---|---|---|---|---|---|---|
| Value | |||||||||
| P/E TTM | x | - | - | ||||||
| P/B LTM | x | 15.74 | 14.87 | ||||||
| P/S LTM | x | 6.52 | 5.95 | ||||||
| P/FCF LTM | x | -570.81 | 1,018.52 | ||||||
| EV/EBITDA LTM | x | -145.65 | -258.35 | ||||||
| EV/Sales LTM | x | 6.39 | 3.35 | ||||||
| Earnings Yield LTM | % | -0.98% | -1.16% | ||||||
| FCF Yield | % | -0.18% | +0.10% | ||||||
| Quality | |||||||||
| ROE | % | -15.47% | -10.63% | ||||||
| ROIC | % | -14.47% | -7.74% | ||||||
| Operating margin | % | -7.23% | -3.66% | ||||||
| Gross margin | % | +62.26% | +61.99% | ||||||
| FCF/Sales | % | -1.14% | +0.58% | ||||||
| Growth and momentum | |||||||||
| EPS Growth YoY | % | - | - | ||||||
| Sales Growth YoY | % | +22.23% | +34.06% | ||||||
| Net Income Growth YoY | % | - | - | ||||||
| FCF Growth | % | - | - | ||||||
| Operating Profit Growth | % | - | - | ||||||
| Dividend and capital structure | |||||||||
| Dividend Yield | % | 0.00% | 0.00% | ||||||
| Dividend Growth | % | - | - | ||||||
| Payout Ratio | % | 0.00% | 0.00% | ||||||
| FCF/Debt | x | -0.13 | 0.08 | ||||||
| Net Debt/EBITDA | x | 2.98 | 4.96 | ||||||
| EBIT/Net interest | x | 0.00 | 0.00 | ||||||
| Net debt/market cap | % | +1.30% | 0.00% | ||||||
| Net debt/Equity | x | -0.32 | -0.46 | ||||||
| Gross debt/equity | x | 0.21 | 0.18 | ||||||
Price target estimates
Based on consensus from external analysts. Not Kvantra's opinion.
Ratings
Based on consensus from external analysts. Not Kvantra's opinion.
ESG
| Metric | 2024 | 2025 | 2026 |
|---|---|---|---|
| ESG-score | |||
| Environmental score | |||
| Social score | |||
| Governance score | |||
| Risk rating |
Company overview
KORU Medical Systems, Inc. is dedicated to the development, manufacturing, and commercialization of mobile medical devices, primarily serving the ambulatory infusion market across both the United States and international territories. The company's primary offerings revolve around mechanical infusion solutions, notably their FREEDOM infusion systems. These comprehensive systems encompass components such as the FREEDOM60 and FreedomEdge syringe drivers, alongside specialized HIgH-Flo subcutaneous safety needle sets and precision flow rate tubing. Beyond their product range, KORU Medical also supplies educational content and training materials to healthcare professionals, patients, and patient advocates. The distribution of their products is managed through a combination of direct sales efforts, partnerships with medical device distributors, and online channels. Established in 1980, the firm's corporate headquarters are situated in Chester, New York.
Similar companies
For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.
KORU Medical Systems, Inc. (KRMD)
No price history available.
Consensus from external analysts. Not Kvantra's opinion.
Based on consensus from external analysts. Not Kvantra's opinion.
KORU Medical Systems, Inc. is dedicated to the development, manufacturing, and commercialization of mobile medical devices, primarily serving the ambulatory infusion market across both the United States and international territories. The company's primary offerings revolve around mechanical infusion solutions, notably their FREEDOM infusion systems. These comprehensive systems encompass components such as the FREEDOM60 and FreedomEdge syringe drivers, alongside specialized HIgH-Flo subcutaneous safety needle sets and precision flow rate tubing. Beyond their product range, KORU Medical also supplies educational content and training materials to healthcare professionals, patients, and patient advocates. The distribution of their products is managed through a combination of direct sales efforts, partnerships with medical device distributors, and online channels. Established in 1980, the firm's corporate headquarters are situated in Chester, New York.
Unlock all fundamental data
Sign up for FreeUnlock all fundamental data
Sign up for Free